Ilias Karaiskos

6.4k total citations · 1 hit paper
56 papers, 3.6k citations indexed

About

Ilias Karaiskos is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Ilias Karaiskos has authored 56 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Medicine, 36 papers in Pharmacology and 25 papers in Epidemiology. Recurrent topics in Ilias Karaiskos's work include Antibiotic Resistance in Bacteria (43 papers), Antibiotics Pharmacokinetics and Efficacy (36 papers) and Pneumonia and Respiratory Infections (11 papers). Ilias Karaiskos is often cited by papers focused on Antibiotic Resistance in Bacteria (43 papers), Antibiotics Pharmacokinetics and Efficacy (36 papers) and Pneumonia and Respiratory Infections (11 papers). Ilias Karaiskos collaborates with scholars based in Greece, Australia and United States. Ilias Karaiskos's co-authors include Helen Giamarellou, Irene Galani, Maria Souli, Anastasia Antoniadou, Lambrini Galani, Konstantinos Pontikis, Fotini Baziaka, Garyphallia Poulakou, Lena E. Friberg and Evangelos Papadomichelakis and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

Ilias Karaiskos

56 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

2019 637 citations Brian T. Tsuji, Jason M. Pogue et al. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilias Karaiskos Greece	30	3.0k	2.1k	1.4k	771	440	56	3.6k
Yoshinori Yamano Japan	30	2.9k 1.0×	2.2k 1.1×	706 0.5×	958 1.2×	569 1.3×	101	3.6k
Alexandre Prehn Zavascki Brazil	35	3.5k 1.2×	2.4k 1.1×	1.5k 1.1×	848 1.1×	629 1.4×	116	4.9k
Maria Souli Greece	32	2.5k 0.8×	1.2k 0.6×	919 0.7×	773 1.0×	670 1.5×	71	3.3k
Shazad Mushtaq United Kingdom	36	3.5k 1.2×	2.2k 1.1×	1.1k 0.8×	1.0k 1.3×	741 1.7×	86	4.2k
Irene Galani Greece	32	2.6k 0.9×	1.2k 0.6×	838 0.6×	696 0.9×	800 1.8×	77	3.3k
Masakatsu Tsuji Japan	24	2.4k 0.8×	1.8k 0.9×	592 0.4×	776 1.0×	417 0.9×	49	2.8k
Magdalena A. Taracila United States	33	2.8k 1.0×	1.5k 0.7×	848 0.6×	507 0.7×	786 1.8×	75	3.5k
Phillip J. Bergen Australia	29	2.2k 0.7×	1.6k 0.8×	893 0.7×	380 0.5×	203 0.5×	79	3.0k
Brian A. Potoski United States	30	2.4k 0.8×	1.5k 0.7×	1.3k 1.0×	858 1.1×	493 1.1×	55	3.7k
Samuel K. Bouchillon United States	31	1.9k 0.6×	1.1k 0.5×	683 0.5×	825 1.1×	425 1.0×	51	2.6k

Countries citing papers authored by Ilias Karaiskos

Since Specialization

Citations

This map shows the geographic impact of Ilias Karaiskos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilias Karaiskos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilias Karaiskos more than expected).

Fields of papers citing papers by Ilias Karaiskos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilias Karaiskos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilias Karaiskos. The network helps show where Ilias Karaiskos may publish in the future.

Co-authorship network of co-authors of Ilias Karaiskos

This figure shows the co-authorship network connecting the top 25 collaborators of Ilias Karaiskos. A scholar is included among the top collaborators of Ilias Karaiskos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilias Karaiskos. Ilias Karaiskos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ioannidis, Konstantinos, Elisabet I. Nielsen, Lamprini Galani, et al.. (2024). Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF). International Journal of Antimicrobial Agents. 65(1). 107394–107394. 4 indexed citations

Galani, Irene, et al.. (2024). In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. Journal of Antimicrobial Chemotherapy. 79(5). 1101–1108. 2 indexed citations

Giacobbe, Daniele Roberto, Vincenzo Di Pilato, Ilias Karaiskos, et al.. (2023). Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades. Annals of Medicine. 55(1). 101–113. 16 indexed citations

Koutserimpas, Christos, Ilias Karaiskos, & Maria Piagkou. (2023). The Insertion of Threaded Acetabulum Components: Indications According to Specific Acetabulum Anatomy and Methods to Avoid Pitfalls. Cureus. 15(12). e50824–e50824. 1 indexed citations

Giamarellou, Helen, et al.. (2023). Antimicrobial Stewardship in the Hospital Setting: A Narrative Review. Antibiotics. 12(10). 1557–1557. 25 indexed citations

Koutserimpas, Christos, et al.. (2023). Posterior Dislocation of the Shoulder: The Light-Bulb Sign. Cureus. 15(10). e47800–e47800. 2 indexed citations

Karaiskos, Ilias, et al.. (2023). High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review. Microorganisms. 11(6). 1459–1459. 11 indexed citations

Gkoufa, Aikaterini, Tomás Sou, Ilias Karaiskos, et al.. (2022). Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulisation of CMS among patients with ventilator-associated pneumonia. International Journal of Antimicrobial Agents. 59(6). 106588–106588. 12 indexed citations

Giacobbe, Daniele Roberto, Andrea Cortegiani, Ilias Karaiskos, et al.. (2021). Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis. Journal of Fungi. 7(3). 176–176. 4 indexed citations

10.

Li, Chen, Jason M. Pogue, Varun Sharma, et al.. (2020). Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study. JMIR mhealth and uhealth. 8(12). e26593–e26593. 1 indexed citations

11.

Li, Chen, Jason M. Pogue, Varun Sharma, et al.. (2020). ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study. JMIR mhealth and uhealth. 8(12). e20525–e20525. 4 indexed citations

12.

Tsuji, Brian T., Jason M. Pogue, Alexandre Prehn Zavascki, et al.. (2019). International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 39(1). 10–39. 637 indexed citations breakdown →

13.

Karaiskos, Ilias, Styliani Lagou, Konstantinos Pontikis, Vasiliki Rapti, & Garyphallia Poulakou. (2019). The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How. Frontiers in Public Health. 7. 151–151. 194 indexed citations

14.

Galani, Irene, et al.. (2019). In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016. European Journal of Clinical Microbiology & Infectious Diseases. 38(6). 1143–1150. 40 indexed citations

15.

Pitt, Miranda E., Alysha G. Elliott, Minh Duc Cao, et al.. (2018). Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae. Microbial Genomics. 4(3). 54 indexed citations

16.

Souli, Maria, et al.. (2017). Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae. European Journal of Clinical Microbiology & Infectious Diseases. 36(7). 1305–1315. 44 indexed citations

17.

Karaiskos, Ilias, Lena E. Friberg, Lambrini Galani, et al.. (2016). Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration. International Journal of Antimicrobial Agents. 48(3). 337–341. 24 indexed citations

18.

Karaiskos, Ilias, Maria Souli, & Helen Giamarellou. (2015). Plazomicin: an investigational therapy for the treatment of urinary tract infections. Expert Opinion on Investigational Drugs. 24(11). 1501–1511. 30 indexed citations

19.

Giamarellou, Helen, Lambrini Galani, Fotini Baziaka, & Ilias Karaiskos. (2013). Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 57(5). 2388–2390. 105 indexed citations

20.

Katsarolis, Ioannis, Garyphallia Poulakou, Jenny Kourea-Kremastinou, et al.. (2009). Acute uncomplicated cystitis: from surveillance data to a rationale for empirical treatment. International Journal of Antimicrobial Agents. 35(1). 62–67. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact